Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 58 min ago
PreprintCC BYbioRxiv

Rab11-exosome biogenesis regulators mediate Aβ-induced intercellular propagation of endolysosomal trafficking defects and neurodegeneration

  1. 1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK

Abstract

Alzheimer's Disease (AD) is characterised by two histopathological hallmarks, intracellular tau-containing neurofibrillary tangles and extracellular amyloid plaques containing {beta}-amyloid (A{beta}), a specific cleavage product of Amyloid Precursor Protein (APP). Initiation of A{beta}-induced neuronal pathology, however, has been postulated to involve intracellular events affecting endolysosomal trafficking that can propagate between cells. Recent studies in non-neuronal Drosophila secondary cells (SCs) have revealed that A{beta} interferes with APP-regulated protein aggregation events, which package signalling molecules into insoluble dense-core granules (DCGs) during normal regulated secretion, inducing endolysosomal defects that are transferred to other cells. Here, using SCs, we show that knockdown of the gene encoding accessory ESCRT-III protein Chmp5, which selectively regulates the formation of intraluminal vesicles (ILVs) inside SC DCG compartments that are subsequently released as Rab11-exosomes, inhibits propagation of A{beta}-induced endolysosomal trafficking defects. Furthermore, knocking down Chmp5 or other accessory ESCRT-III genes also suppresses A{beta}-induced, neurodegeneration-dependent morphological defects in the Drosophila eye. We conclude that genes controlling the Rab11-exosome biogenesis pathway play a key role in both A{beta}-induced endolysosomal trafficking defects associated with aberrant regulated secretion and cellular events leading to neurodegeneration. Our findings indicate these processes are linked and may suggest new target pathways for future development of AD therapeutics.

Related

  1. TM6SF2 acts at ER membrane contact sites to enable RAB7-dependent endolysosomal VLDL secretion and maintain Golgi structure
    Emad Heidary Arash, Marko Groeger, James P. Grenert +4
    Cell ReportsPeer-reviewedCC BY 4.0Cell biologyCrossref
  2. ApoE4 impairs astrocyte lipid droplet formation via endolysosomal dysfunction
    I. Ralhan, J.-Y. Bae, N. Y. Lee +6
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  3. Cardiomyocyte Identity Crisis Without Regenerative Re-entry: A Multi-Scale Atlas of Incomplete Dedifferentiation and Intercellular Communication Rewiring in the Infarcted Human Heart
    s. qiao, L. Li, C. He +1
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  4. Multidimensional regulation of hepatic macrophages in chronic liver disease: from metabolic reprogramming to intercellular and interorgan crosstalk
    Che Xu, Xin-Yu Zhu, Hai-Na Xie +3
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  5. Ribosomal biogenesis factor links ribosome homeostasis to host relevant stress survival in Aspergillus fumigatus
    J. A. Adeoye, H. Hayby, N. Shlezinger
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
BibTeX
@misc{cording2026rab11exosome,
  title = {{Rab11-exosome biogenesis regulators mediate Aβ-induced intercellular propagation of endolysosomal trafficking defects and neurodegeneration}},
  author = {A. Cording and B. Verma and A. Arous and S. Rice and H. Vine and L. Blincowe and S. M. Wainwright and P. J. Singh and D. C. I. Goberdhan and C. Wilson},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.17.752336},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.17.752336v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Rab11-exosome biogenesis regulators mediate Aβ-induced intercellular propagation of endolysosomal trafficking defects and neurodegeneration
AU  - A. Cording
AU  - B. Verma
AU  - A. Arous
AU  - S. Rice
AU  - H. Vine
AU  - L. Blincowe
AU  - S. M. Wainwright
AU  - P. J. Singh
AU  - D. C. I. Goberdhan
AU  - C. Wilson
PY  - 2026
DA  - 2026/09/17
PB  - bioRxiv
DO  - 10.64898/2026.09.17.752336
UR  - https://www.biorxiv.org/content/10.64898/2026.09.17.752336v1
AB  - Alzheimer's Disease (AD) is characterised by two histopathological hallmarks, intracellular tau-containing neurofibrillary tangles and extracellular amyloid plaques containing {beta}-amyloid (A{beta}), a specific cleavage product of Amyloid Precursor Protein (APP). Initiation of A{beta}-induced neuronal pathology, however, has been postulated to involve intracellular events affecting endolysosomal trafficking that can propagate between cells. Recent studies in non-neuronal Drosophila secondary cells (SCs) have revealed that A{beta} interferes with APP-regulated protein aggregation events, which package signalling molecules into insoluble dense-core granules (DCGs) during normal regulated secretion, inducing endolysosomal defects that are transferred to other cells. Here, using SCs, we show that knockdown of the gene encoding accessory ESCRT-III protein Chmp5, which selectively regulates the formation of intraluminal vesicles (ILVs) inside SC DCG compartments that are subsequently released as Rab11-exosomes, inhibits propagation of A{beta}-induced endolysosomal trafficking defects. Furthermore, knocking down Chmp5 or other accessory ESCRT-III genes also suppresses A{beta}-induced, neurodegeneration-dependent morphological defects in the Drosophila eye. We conclude that genes controlling the Rab11-exosome biogenesis pathway play a key role in both A{beta}-induced endolysosomal trafficking defects associated with aberrant regulated secretion and cellular events leading to neurodegeneration. Our findings indicate these processes are linked and may suggest new target pathways for future development of AD therapeutics.
ER  -